The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.The reported patient effect of occlusion is listed in the supera peripheral stent system instructions for use as a potential adverse event associated to the use of the device.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that resistance was met with the heavily tortuous anatomy resulting in the reported difficult to advance.During deployment the tip/nose cone inadvertently got caught on the end of the stent resulting in the reported difficult/delayed activation/deployment and the reported difficult to remove.Interaction/manipulation of the compromised device ultimately resulted in the reported tip material separation.The reported difficulties possibly caused/contributed to the reported patient effects; however, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The treatment appears to be related to the operational context of the procedure.As reported, the tip was left floating in healthy artery.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|